Healthcare Finance News May 30, 2019
The case for precision medicine has been made. Now, how do we make it happen?
CFOs, and others, know a change is coming and they don’t want to make millions of dollars in technology investments that could become obsolete in 5-10 years due to advancements in the genetic space, according to Michael Allen, CFO at OSF HealthCare and incoming chairman of the Healthcare Financial Management Association.
“The Eric Topol’s of the world have spoken, the topic is coming up in various degrees,” said Allen, referring to outspoken cardiologist Eric...